GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
I

Inhibrx Biosciences INBX · USD

Health Care · US listing · 🇺🇸 United States

Compare

91.74

+8.54%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on Inhibrx Biosciences

Our reporting

Next results

13 Nov 2026

Due on 13 Nov 2026. Analysts expect earnings of -2.45 a share on revenue of $1.9m.

Past results

Reported against what analysts expected

13 Aug 202612 Aug 202614 May 202619 Mar 202614 Nov 202513 Aug 2025
Earnings per share-2.34-1.85-2.15-2.11-2.28-1.85
Forecast-2.28-2.50-2.37-2.08-2.08-2.92
Revenue—————$1.3m
Forecast———$1.1m——

Key events

  1. 19 Aug 2020Listed

Inhibrx Biosciences in the news

Headlines from other publishers, linked to their own pages.

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.